161 related articles for article (PubMed ID: 10446773)
1. An immunohistochemical study of basal cell carcinoma and trichoepithelioma.
Poniecka AW; Alexis JB
Am J Dermatopathol; 1999 Aug; 21(4):332-6. PubMed ID: 10446773
[TBL] [Abstract][Full Text] [Related]
2. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
Kirchmann TT; Prieto VG; Smoller BR
Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
[TBL] [Abstract][Full Text] [Related]
3. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens.
Swanson PE; Fitzpatrick MM; Ritter JH; Glusac EJ; Wick MR
J Cutan Pathol; 1998 Mar; 25(3):153-9. PubMed ID: 9550314
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
[TBL] [Abstract][Full Text] [Related]
5. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas.
Basarab T; Orchard G; Russell-Jones R
Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103
[TBL] [Abstract][Full Text] [Related]
6. bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas.
Smoller BR; Van de Rijn M; Lebrun D; Warnke RA
Br J Dermatol; 1994 Jul; 131(1):28-31. PubMed ID: 8043419
[TBL] [Abstract][Full Text] [Related]
7. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
Smith KJ; Williams J; Corbett D; Skelton H
Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
[TBL] [Abstract][Full Text] [Related]
8. Solar keratosis can be distinguished from superficial basal cell carcinoma by expression of bcl-2.
Mills AE
Am J Dermatopathol; 1997 Oct; 19(5):443-5. PubMed ID: 9335236
[TBL] [Abstract][Full Text] [Related]
9. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Thewes M; Worret WI; Engst R; Ring J
Am J Dermatopathol; 1998 Apr; 20(2):140-2. PubMed ID: 9557781
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparison of cutaneous lymphadenoma, trichoblastoma, and basal cell carcinoma: support for classification of lymphadenoma as a variant of trichoblastoma.
McNiff JM; Eisen RN; Glusac EJ
J Cutan Pathol; 1999 Mar; 26(3):119-24. PubMed ID: 10235376
[TBL] [Abstract][Full Text] [Related]
12. Immunostaining for CD34 to determine trichoepithelioma.
Bryant D; Penneys NS
Arch Dermatol; 1995 May; 131(5):616-7. PubMed ID: 7537953
[No Abstract] [Full Text] [Related]
13. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
14. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
15. Merkel cells and sclerosing epithelial neoplasms.
Abesamis-Cubillan E; El-Shabrawi-Caelen L; LeBoit PE
Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455
[TBL] [Abstract][Full Text] [Related]
16. Trichoblastoma and basal cell carcinoma are neoplasms with follicular differentiation sharing the same profile of cytokeratin intermediate filaments.
Schirren CG; Rütten A; Kaudewitz P; Diaz C; McClain S; Burgdorf WH
Am J Dermatopathol; 1997 Aug; 19(4):341-50. PubMed ID: 9261468
[TBL] [Abstract][Full Text] [Related]
17. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
Choi CW; Park HS; Kim YK; Lee SH; Cho KH
J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
[TBL] [Abstract][Full Text] [Related]
18. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
Costache M; Bresch M; Böer A
Histopathology; 2008 Jun; 52(7):865-76. PubMed ID: 18462369
[TBL] [Abstract][Full Text] [Related]
20. The management of solitary trichoepithelioma versus basal cell carcinoma.
Votruba M; Collins CM; Harrad RA
Eye (Lond); 1998; 12 ( Pt 1)():43-6. PubMed ID: 9614515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
